Opioids

CMS Issues New Regulations Aimed at Identifying and Limiting Potential Opioid Abuse

On April 2, 2018, the Centers for Medicare and Medicaid Services (CMS) issued a final rule which updated regulations for Medicare Advantage Plans (MAP) and Medicare Part D programs. The primary foc...

CMS and Opioid Medications - Will CMS Address Opioids in 2018?

Ever since Center for Medicare & Medicaid Services (CMS) started to individually price medications in early 2009, prescription medications, especially opioid medications, have become major cost...

Opana ER Will Be Removed from the Marketplace

Opana ER will be voluntarily removed from the marketplace, per the announcement last week of manufacturer Endo International plc. This follows the FDA’s suggestion that we blogged about last month...

FDA request to remove Opana ER may be good news for WCMSAs

The FDA has recently intervened in the escalating fight against opioid abuse. The agency has requested that Opana ER, a long-acting opioid medication, be removed from the market due to the high ris...